keyword
https://read.qxmd.com/read/38627776/the-value-of-lung-function-assessment-and-testin-expression-detection-in-clinicopathological-features-and-prognosis-of-nsclc-patients
#21
JOURNAL ARTICLE
Yanmin Zhang, Gaoming Wang, Qian Zhang, Qian Wang, Jing Luo, Chunhua Ling
OBJECTIVE: The aim of this study is to investigate the clinical value and potential prognostic significance of lung function assessment and Testin expression in non-small cell lung cancer (NSCLC) patients. METHODS: The NSCLC patients were classified into three groups according to lung function: group of normal lung function, group of PRISm (preserved ratio impaired spirometry) (FEV1, forced expiratory volume during the first second < 80% predicted and FEV1/FVC (forced vital capacity) ≥ 70%) and group of COPD (chronic obstructive pulmonary disease) (FEV1/FVC < 70%)...
April 16, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38627696/decreased-serpin-c1-in-extracellular-vesicles-predicts-response-to-methotrexate-treatment-in-patients-with-pulmonary-sarcoidosis
#22
JOURNAL ARTICLE
Raisa Kraaijvanger, Montse Janssen Bonás, Jan C Grutters, Ioanna Paspali, Marcel Veltkamp, Dominique P V de Kleijn, Coline H M van Moorsel
BACKGROUND: Sarcoidosis is a systemic granulomatous disease of unknown etiology primarily affecting the lungs. Treatment is needed when disease symptoms worsen and organ function deteriorates. In pulmonary sarcoidosis, prednisone and methotrexate (MTX) are the most common anti-inflammatory therapies. However, there is large inter-patient variability in response to treatment, and predictive response markers are currently lacking. OBJECTIVE: In this study, we investigated the predictive potential of biomarkers in extracellular vesicles (EVs) isolated from biobanked serum of patients with pulmonary sarcoidosis stored prior to start of therapy...
April 16, 2024: Respiratory Research
https://read.qxmd.com/read/38622894/novel-utilization-and-quantification-of-xsight-diaphragm-tracking-for-respiratory-motion-compensation-in-cyberknife-synchrony-treatment-of-liver-tumors
#23
JOURNAL ARTICLE
Jianping Zhang, Lin Wang, Chenyu Xie, Zhiyu Yang, Benhua Xu, Xiaobo Li
PURPOSE: The Xsight lung tracking system (XLTS) utilizes an advanced image processing algorithm to precisely identify the position of a tumor and determine its location in orthogonal x-ray images, instead of finding fiducials, thereby minimizing the risk of fiducial insertion-related side effects. To assess and gauge the effectiveness of CyberKnife Synchrony in treating liver tumors located in close proximity to or within the diaphragm, we employed the Xsight diaphragm tracking system (XDTS), which was based on the XLTS...
April 15, 2024: Journal of Applied Clinical Medical Physics
https://read.qxmd.com/read/38622884/single-cell-and-bulk-rna-sequencing-reveal-spp1-and-cxcl12-as-cell-to-cell-communication-markers-to-predict-prognosis-in-lung-adenocarcinoma
#24
JOURNAL ARTICLE
Zengtuan Xiao, Zhe Nian, Mengzhe Zhang, Zuo Liu, Pengpeng Zhang, Zhenfa Zhang
Lung adenocarcinoma (LUAD) generally presents as an immunosuppressive microenvironment. The characteristics of cell-to-cell communication in the LUAD microenvironment has been unclear. In this study, the LUAD bulk RNA-seq data and single-cell RNA-seq data were retrieved from public dataset. Differential expression genes (DEGs) between LUAD tumor and adjacent non-tumor tissues were calculated by limma algorithm, and then detected by PPI, KEGG, and GO analysis. Cell-cell interactions were explored using the single-cell RNA-seq data...
April 15, 2024: Environmental Toxicology
https://read.qxmd.com/read/38619623/t-cell-subsets-and-cytokines-are-indicative-of-neoadjuvant-chemoimmunotherapy-responses-in-nsclc
#25
JOURNAL ARTICLE
Ling Yi, Ziwei Xu, Tianyu Ma, Chong Wang, Panjian Wei, Bo Xiao, Hongtao Zhang, Nanying Che, Zhidong Liu, Yi Han
PURPOSE: Neoadjuvant PD-1 blockade combined with chemotherapy is a promising treatment for resectable non-small cell lung cancer (NSCLC), yet the immunological mechanisms contributing to tumor regression and biomarkers corresponding to different pathological responses remain unclear. METHODS: Using dynamic and paired blood samples from NSCLC patients receiving neoadjuvant chemoimmunotherapy, we analyzed the frequencies of CD8 + T-cell and Treg subsets and their dynamic changes during neoadjuvant treatment through flow cytometry...
April 15, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38618443/neutrophil-to-lymphocyte-ratio-and-blood-eosinophil-levels-as-inflammatory-indicators-in-smoker-and-non-smoker-young-adult-patients-with-chronic-obstructive-pulmonary-disease-at-a-tertiary-care-hospital
#26
JOURNAL ARTICLE
Shah Mohammad Abbas Waseem, Imrana Masood, Anwar H Siddiqui, Mohd Amir, Syed Hilal Hussain, Syed Haider Mehdi Husaini
Background Inflammatory markers are elevated in chronic obstructive pulmonary disease (COPD) and can be quantified to detect severity, prognosis, mortality risk, and response to treatment. However, the estimation costs are high. The blood neutrophil-to-lymphocyte ratio (NLR) and eosinophil levels are emerging as biomarkers in COPD, yet there is a paucity of data. Aim and objectives This study was designed to elucidate the roles of the NLR and eosinophil levels in smokers and non-smokers with stable COPD male subjects, correlating them with lung functions...
March 2024: Curēus
https://read.qxmd.com/read/38615437/diagnostic-and-predictive-significance-of-the-ferroptosis-related-gene-txnip-in-lung-adenocarcinoma-stem-cells-based-on-multi-omics
#27
JOURNAL ARTICLE
Yuanyuan Zheng, Wei Yang, Weixuan Wu, Feng Jin, Dehua Lu, Jing Gao, Shubin Wang
BACKGROUND: Lung cancer stands as the foremost cause of cancer-related fatalities globally. The presence of cancer stem cells (CSCs) poses a challenge, rendering current targeted tumor therapies ineffective. This study endeavors to investigate a novel therapeutic approach focusing on ferroptosis and delves into the expression of ferroptosis-related genes within lung CSCs. METHODS: We systematically examined RNA-seq datasets derived from lung tumor cells (LTCs) and lung cancer stem cells (LSCs), as previously investigated in our research...
April 13, 2024: Translational Oncology
https://read.qxmd.com/read/38614190/predicting-impaired-cardiopulmonary-exercise-capacity-in-patients-with-atrial-fibrillation-using-a-simple-echocardiographic-marker
#28
JOURNAL ARTICLE
Hung-Jui Chuang, Lung-Chun Lin, An-Li Yu, Yen-Bin Liu, Lian-Yu Lin, Hui-Chun Huang, Li-Ting Ho, Ling-Ping Lai, Wen-Jone Chen, Yi-Lwung Ho, Ssu-Yuan Chen, Chih-Chieh Yu
BACKGROUND: Exercise intolerance is a common symptom associated with atrial fibrillation (AF). However, echocardiographic markers that can predict impaired exercise capacity are lacking. OBJECTIVE: To investigate the association between echocardiographic parameters and exercise capacity assessed via cardiopulmonary exercise testing (CPET) in patients with AF. METHODS: This single-center prospective study enrolled patients with AF who underwent echocardiography and CPET to evaluate exercise capacity at a tertiary center for AF management from 2020 to 2022...
April 11, 2024: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://read.qxmd.com/read/38612418/six-gene-signature-for-differential-diagnosis-and-therapeutic-decisions-in-non-small-cell-lung-cancer-a-validation-study
#29
JOURNAL ARTICLE
Radoslaw Charkiewicz, Anetta Sulewska, Piotr Karabowicz, Grzegorz Lapuc, Alicja Charkiewicz, Marcin Kraska, Joanna Pancewicz, Malgorzata Lukasik, Miroslaw Kozlowski, Rafal Stec, Dominika Ziembicka, Weronika Piszcz, Wojciech Miltyk, Wieslawa Niklinska
Non-small-cell lung cancer (NSCLC) poses a challenge due to its heterogeneity, necessitating precise histopathological subtyping and prognostication for optimal treatment decision-making. Molecular markers emerge as a potential solution, overcoming the limitations of conventional methods and supporting the diagnostic-therapeutic interventions. In this study, we validated the expression of six genes ( MIR205HG , KRT5 , KRT6A , KRT6C , SERPINB5 , and DSG3 ), previously identified within a 53-gene signature developed by our team, utilizing gene expression microarray technology...
March 23, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38606165/unraveling-the-tumor-immune-microenvironment-of-lung-adenocarcinoma-using-single-cell-rna-sequencing
#30
REVIEW
Lele Song, Yuan Gong, Erpeng Wang, Jianchun Huang, Yuemin Li
Tumor immune microenvironment (TIME) and its indications for lung cancer patient prognosis and therapeutic response have become new hotspots in cancer research in recent years. Tumor cells, immune cells, various regulatory factors, and their interactions in the TIME have been suggested to commonly influence lung cancer development and therapeutic outcome. The heterogeneity of TIME is composed of dynamic immune-related components, including various cancer cells, immune cells, cytokine/chemokine environments, cytotoxic activity, or immunosuppressive factors...
2024: Therapeutic Advances in Medical Oncology
https://read.qxmd.com/read/38606156/myositis-associated-antibodies-predict-the-severity-of-lung-involvement-in-adult-patients-with-inflammatory-myositis-a-cohort-study-of-70-adult-patients-with-myositis-in-a-single-center
#31
JOURNAL ARTICLE
Josefin Marklund, Balsam Hanna, Tao Jin, Rille Pullerits
INTRODUCTION: Idiopathic inflammatory myopathies (IIMs) encompass a diverse group of diseases characterized by considerable variability in clinical manifestations, antibody profiles, and responsiveness to immunosuppressive therapies. This study aimed to investigate the association between organ involvement and distinct myositis autoantibodies in individuals with IIM in a single-center cohort. METHODS: Patients with ICD diagnoses M33.1, M33.2, M33.9, or M609 who (1) had been tested with Euroline blot assay for myositis autoantibodies and (2) met the classification criteria of definite/probable polymyositis (PM) or dermatomyositis (DM), anti-synthetase syndrome (ASS), or inclusion body myositis (IBM) were included...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38605303/the-application-of-different-machine-learning-models-based-on-pet-ct-images-and-egfr-in-predicting-brain-metastasis-of-adenocarcinoma-of-the-lung
#32
JOURNAL ARTICLE
Chao Kong, Xiaoyan Yin, Jingmin Zou, Changsheng Ma, Kai Liu
OBJECTIVE: To explore the value of six machine learning models based on PET/CT radiomics combined with EGFR in predicting brain metastases of lung adenocarcinoma. METHODS: Retrospectively collected 204 patients with lung adenocarcinoma who underwent PET/CT examination and EGFR gene detection before treatment from Cancer Hospital Affiliated to Shandong First Medical University in 2020. Using univariate analysis and multivariate logistic regression analysis to find the independent risk factors for brain metastasis...
April 11, 2024: BMC Cancer
https://read.qxmd.com/read/38605064/enhancing-nsclc-recurrence-prediction-with-pet-ct-habitat-imaging-ctdna-and-integrative-radiogenomics-blood-insights
#33
JOURNAL ARTICLE
Sheeba J Sujit, Muhammad Aminu, Tatiana V Karpinets, Pingjun Chen, Maliazurina B Saad, Morteza Salehjahromi, John D Boom, Mohamed Qayati, James M George, Haley Allen, Mara B Antonoff, Lingzhi Hong, Xin Hu, Simon Heeke, Hai T Tran, Xiuning Le, Yasir Y Elamin, Mehmet Altan, Natalie I Vokes, Ajay Sheshadri, Julie Lin, Jianhua Zhang, Yang Lu, Carmen Behrens, Myrna C B Godoy, Carol C Wu, Joe Y Chang, Caroline Chung, David A Jaffray, Ignacio I Wistuba, J Jack Lee, Ara A Vaporciyan, Don L Gibbons, John Heymach, Jianjun Zhang, Tina Cascone, Jia Wu
While we recognize the prognostic importance of clinicopathological measures and circulating tumor DNA (ctDNA), the independent contribution of quantitative image markers to prognosis in non-small cell lung cancer (NSCLC) remains underexplored. In our multi-institutional study of 394 NSCLC patients, we utilize pre-treatment computed tomography (CT) and 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) to establish a habitat imaging framework for assessing regional heterogeneity within individual tumors...
April 11, 2024: Nature Communications
https://read.qxmd.com/read/38604053/ards-in-solid-organ-transplant-recipients-hospitalized-for-covid-19-based-on-the-2023-new-definition
#34
JOURNAL ARTICLE
Jun Tang, Yang Zhou, Linmei Gong, Jiayi Deng, Yihao Yuan, Yanjun Zhong, Jinxiu Li, Guyi Wang
BACKGROUND: Solid organ transplant recipients (SOTRs) are more likely to suffer complications after being infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). OBJECTIVES: We aimed to describe the clinical features of SOTRs infected with SARS-CoV-2 and to assess independent risk factors associated with the development of acute respiratory distress syndrome (ARDS) following COVID-19 infection in SOTRs based on the new ARDS definition. METHODS: 358 SOTRs infected with SARS-CoV-2 were recruited and divided into two groups, patients with ARDS (n = 81) and patients without ARDS (n = 277)...
April 10, 2024: Heart & Lung: the Journal of Critical Care
https://read.qxmd.com/read/38601803/discovery-of-potential-epidermal-growth-factor-receptor-inhibitors-from-black-pepper-for-the-treatment-of-lung-cancer-an-in-silico-approach
#35
JOURNAL ARTICLE
Olusola Olalekan Elekofehinti, Ifeoluwa Rachael Adetoyi, Hannah Oluwaseun Popoola, Folasade Oluwatobiloba Ayodeji, Foluso Adeola Taiwo, Moses Orimoloye Akinjiyan, Omowunmi Funmilayo Koledoye, Opeyemi Iwaloye, Abayomi Emmanuel Adegboyega
UNLABELLED: A tyrosine kinase receptor known as epidermal growth factor receptor (EGFR) is one of the main tumour markers in many cancer types and also plays a crucial role in cell proliferation, differentiation, angiogenesis, and apoptosis, which is a result of the auto-phosphorylations (kinase activity enhancement) that trigger signals involved in different cellular processes. Due to the discovery that non-small cell lung cancer (NSCLC) is a cause of this kinase activity enhancement, so far, several inhibitors have been tested against EGFR, but the side effects of these inhibitors necessitate an urgent measure to come up with an inhibitor that will be more specific to the cancer cells and not affect self-cells...
2024: In Silico Pharmacology
https://read.qxmd.com/read/38601457/improved-diagnostic-accuracy-with-three-lung-tumor-markers-compared-to-six-marker-panel
#36
JOURNAL ARTICLE
Ami Izawa, Yu Hara, Nobuyuki Horita, Suguru Muraoka, Megumi Kaneko, Ayami Kaneko, Kohei Somekawa, Momo Hirata, Yukiko Otsu, Hiromi Matsumoto, Ryo Nagasawa, Katsushi Tanaka, Sousuke Kubo, Kota Murohashi, Ayako Aoki, Hiroaki Fujii, Keisuke Watanabe, Nobuaki Kobayashi, Kenji Miura, Hideaki Nakajima, Takeshi Kaneko
BACKGROUND: Combining multiple tumor markers increases sensitivity for lung cancer diagnosis in the cost of false positive. However, some would like to check as many as tumor markers in the fear of missing cancer. We though to propose a panel of fewer tumor markers for lung cancer diagnosis. METHODS: Patients with suspected lung cancer who simultaneously underwent all six tests [carcinoembryonic antigen (CEA), cytokeratin-19 fragment (CYFRA), squamous cell carcinoma-associated antigen (SCC), neuron-specific enolase (NSE), pro-gastrin-releasing peptide (ProGRP), and sialyl Lewis-X antigen (SLX)] were included...
March 29, 2024: Translational Lung Cancer Research
https://read.qxmd.com/read/38601456/revisiting-the-impact-of-clinicopathologic-characteristics-in-pd-l1-profile-in-a-large-cohort-of-non-small-cell-lung-cancer
#37
JOURNAL ARTICLE
Youngjin Kang, Seung-Eun Lee, Chul Hwan Kim, Yoo Jin Lee
BACKGROUND: Immunotherapies using anti-programmed cell death ligand-1 (PD-L1) agents have recently shown remarkable outcomes in patients with non-small cell lung cancer (NSCLC). However, there was a poor correlation between PD-L1 expression and treatment response. Many researchers have focused on the clinicopathological factors associated with prognosis, but the results are conflicting. In the present study, we investigated the clinicopathological significance of PD-L1 overexpression in NSCLC cells...
March 29, 2024: Translational Lung Cancer Research
https://read.qxmd.com/read/38596438/salivary-c-reactive-protein-and-mean-platelet-volume-as-possible-diagnostic-markers-for-late-onset-neonatal-pneumonia
#38
JOURNAL ARTICLE
Wafaa Ahmed Metwali, Abdelrahman Mohamed Elmashad, Sahar Mohey Eldin Hazzaa, Mohammed Al-Beltagi, Mohamed Basiony Hamza
BACKGROUND: Neonatal sepsis, a formidable threat to newborns, is a leading cause of neonatal mortality, with late-onset sepsis manifesting after 72 hours post-birth being particularly concerning. Pneumonia, a prevalent sepsis presentation, poses a significant risk, especially during the neonatal phase when lung defenses are compromised. Accurate diagnosis of pneumonia is imperative for timely and effective interventions. Saliva, a minimally invasive diagnostic medium, holds great promise for evaluating infections, especially in infants...
March 9, 2024: World Journal of Clinical Pediatrics
https://read.qxmd.com/read/38596315/cat-e-a-comprehensive-web-tool-for-exploring-cancer-targeting-strategies
#39
JOURNAL ARTICLE
Rana Salihoglu, Johannes Balkenhol, Gudrun Dandekar, Chunguang Liang, Thomas Dandekar, Elena Bencurova
Identifying potential cancer-associated genes and drug targets from omics data is challenging due to its diverse sources and analyses, requiring advanced skills and large amounts of time. To facilitate such analysis, we developed Cat-E ( Ca ncer T arget E xplorer), a novel R/Shiny web tool designed for comprehensive analysis with evaluation according to cancer-related omics data. Cat-E is accessible at https://cat-e.bioinfo-wuerz.eu/. Cat-E compiles information on oncolytic viruses, cell lines, gene markers, and clinical studies by integrating molecular datasets from key databases such as OvirusTB, TCGA, DrugBANK, and PubChem...
December 2024: Computational and Structural Biotechnology Journal
https://read.qxmd.com/read/38592088/significantly-elevated-ca-19-9-after-covid-19-vaccination-and-literature-review-of-non-cancerous-cases-with-ca-19-9-1000-u-ml
#40
Jakub Ciesielka, Krzysztof Jakimów, Natalia Tekiela, Laura Peisert, Anna Kwaśniewska, Dariusz Kata, Jerzy Chudek
BACKGROUND: CA 19-9 is a commonly assessed tumor marker, considered characteristic of pancreatic ductal adenocarcinoma (PDAC) and biliary tract cancers; however, the positive predictive value of CA 19.9 is too low, and the usage of CA 19.9 as a screening tool in the healthy population remains controversial. METHODS: The presented case illustrates a reversed diagnosis of highly elevated serum CA 19-9 levels in a 54-year-old female complaining of pain in the epigastric region, shortly after COVID-19 vaccination...
February 23, 2024: Journal of Clinical Medicine
keyword
keyword
74721
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.